Search

Showing "11154" results for ""

News from the Fifteenth International AIDS Conference

Early liver enzyme elevations wane with prolonged HAART treatment in women with HCV

Acetyl-l-carnitine can improve peripheral neuropathy, study shows

UK government to finance vaccine drive by bond sales: model for global AIDS treatment?

Importance of biopsies for confirming cause of muscle disease in HIV patients shown by case reports

Rifampicin and pyrazinamide treatment for latent TB in HIV patients does not carry high risk of liver injury, but editorial still urges caution

A rare human genetic make-up gives the best chance against HIV

Drug-resistant HIV acquired during infection may persist for up to seven years

South Africa forces recall of Cipla’s Duovir in response to WHO concerns

Cambodian study of tenofovir for HIV prevention halted, PM cites `human rights`

HIV causes mitochondrial toxicity, even in absence of drugs

Nevirapine safe and effective in patients with a CD4 cell count below 200

New, accurate TB test approved for use in Europe

Rosiglitazone causes lipomas in HIV-positive man with fat loss

Could anti-cholesterol statins also be low-cost antiretrovirals?

Scientists discover new approaches to purging HIV reservoir

Nucleic acid testing for HIV and HCV making US blood supply safer

Most ‘HAART-associated’ symptoms may not be attributable to drug therapy, study claims

Receive the latest HIV research and conference news

Showing "11154" results for ""

News from the Fifteenth International AIDS Conference

Early liver enzyme elevations wane with prolonged HAART treatment in women with HCV

Acetyl-l-carnitine can improve peripheral neuropathy, study shows

UK government to finance vaccine drive by bond sales: model for global AIDS treatment?

Importance of biopsies for confirming cause of muscle disease in HIV patients shown by case reports

Rifampicin and pyrazinamide treatment for latent TB in HIV patients does not carry high risk of liver injury, but editorial still urges caution

A rare human genetic make-up gives the best chance against HIV

Drug-resistant HIV acquired during infection may persist for up to seven years

South Africa forces recall of Cipla’s Duovir in response to WHO concerns

Cambodian study of tenofovir for HIV prevention halted, PM cites `human rights`

HIV causes mitochondrial toxicity, even in absence of drugs

Nevirapine safe and effective in patients with a CD4 cell count below 200

New, accurate TB test approved for use in Europe

Rosiglitazone causes lipomas in HIV-positive man with fat loss

Could anti-cholesterol statins also be low-cost antiretrovirals?

Scientists discover new approaches to purging HIV reservoir

Nucleic acid testing for HIV and HCV making US blood supply safer

Most ‘HAART-associated’ symptoms may not be attributable to drug therapy, study claims

Receive the latest HIV research and conference news